BUSINESS REGISTRATION NUMBER
BRN 79409390
Live

Hong kong JiaShi Biomedicine CO., Limited

香港佳士生物醫藥有限公司

Registry Verified: 2026-09-10
Jurisdiction: Hong Kong, China

Hong kong JiaShi Biomedicine CO., Limited (香港佳士生物醫藥有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its Business Registration Number (BRN) is 79409390. Incorporated on 2025-12-16, the entity has maintained continuous statutory operations for 10 months, currently holding an active legal status of Live. The registered office is situated at ROOM D07, 8/F, BLOCK 2, KAI TAK FACTORY BUILDING STAGE 2, 99 KING FUK STREET, WONG TAI SIN DISTRICT, KOWLOON, HONG KONG. Regarding statutory filings, pursuant to Section 662 of the Companies Ordinance (Cap. 622), the company is exempt from filing an annual return in its incorporation year, with its first Annual Return (Form NAR1) filing window scheduled for Dec 16 – Jan 27 (within 42 days after its first anniversary); a total of 5 statutory filings (spanning 2025–2026, latest filed on 2026-03-27) are indexed in the registry, comprising 2 officer/secretary change notice(s) (ND2A).

I. Corporate Profile & Statutory Registry Records

Official Chinese Name 香港佳士生物醫藥有限公司 Official English Name Hong kong JiaShi Biomedicine CO., Limited
Company Reg No. (CRN) — (No CRN Registered) Business Reg No. (BRN)
79409390
Incorporation Date 2025-12-16 Company Category Private company limited by shares
Current Legal Status Live Statutory Filing Cycle
2026-12-16
Registered Office Address
ROOM D07, 8/F, BLOCK 2, KAI TAK FACTORY BUILDING STAGE 2, 99 KING FUK STREET, WONG TAI SIN DISTRICT, KOWLOON, HONG KONGKai Tak Factory Building (Stage 2) · View Co-Located Entities →
Significant Controllers (SCR) Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

II. Companies Registry Document Retrieval(Form NNC1 & ND2A Filings)

File Annual Return (NAR1) & Secretary
💡
Statutory Filing Notice: This entity was newly incorporated (under 1 year). Pursuant to Section 662 of the Companies Ordinance (Cap. 622), its first Annual Return (Form NAR1) will be due within 42 days after its first anniversary. To verify founding shareholders, initial directors, and registered office, please retrieve the official stamped Form NNC1 (Incorporation Form) or Articles of Association (A&A) below.
#Filing DateDocument No.Document NamePagesTariffAction
12026-03-2723502387293
ND2A
Notice of Change of Company Secretary and Director (English)
3HK$ 20
22026-02-0222001964693
ND4
Notice of Resignation of Company Secretary and Director (English)
2HK$ 20
32025-12-1670005246462
NNC1
Incorporation Form (Company Limited by Shares) (Chinese)Founding Shareholders & Directors
8HK$ 28
42025-12-1670005246464
A&A
Articles of Association (A&A) (Chinese)
15HK$ 33
52025-12-1640025318618
CI
Certificate of Incorporation (CI)
1HK$ 20

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.

IV. Corporate Statutory Dossier & Legal Status FAQ

Yes. Hong kong JiaShi Biomedicine CO., Limited is a legitimate Hong Kong corporation (Private company limited by shares) duly incorporated under the Companies Ordinance (Cap. 622) on 2025-12-16 (operating for under 1 year (Newly Incorporated)). According to official registers of the Hong Kong Companies Registry (CR), the entity holds an active statutory standing of [Live / In Operation], possessing independent legal personality and full corporate capacity (Statutory verification: September 2026).

The sole statutory identifier for Hong kong JiaShi Biomedicine CO., Limited is its 8-digit Business Registration Number (BRN / Unique Business Identifier UBI): [79409390]. Pursuant to Phase 2 of the Unique Business Identifier (UBI) regime implemented by the Hong Kong Companies Registry on 27 December 2023, the 8-digit BRN issued by the Inland Revenue Department serves as the unified statutory identifier across all government departments for newly incorporated companies, and no separate legacy CRN is issued.

Under the Companies Ordinance (Cap. 622), Hong Kong corporations do not have a 'legal representative' role; executive authority vests in the Board of Directors (Section 643). Because Hong kong JiaShi Biomedicine CO., Limited was incorporated within the past year (2025-12-16), pursuant to Section 662 its first Annual Return (Form NAR1) will be due within 42 days after its 1st incorporation anniversary. Official registry records confirm 5 statutory incorporation dossier(s) archived (latest statutory filing indexed on 2026-03-27: Form ND2A - Notice of Change of Company Secretary and Director (English)). Its founding directors, company secretary, founder member shareholdings, issued share capital, and registered office are definitively recorded in its barcoded Incorporation Form (Form NNC1) and Articles of Association (A&A)—supplemented by any subsequent Return of Allotment (Form NSC1) or Notice of Change of Director (Form ND2A)—available for online retrieval.

The statutory registered office of Hong kong JiaShi Biomedicine CO., Limited on official record is situated at: [ROOM D07, 8/F, BLOCK 2, KAI TAK FACTORY BUILDING STAGE 2, 99 KING FUK STREET, WONG TAI SIN DISTRICT, KOWLOON, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622), every Hong Kong company must maintain a registered office in Hong Kong to which all communications and legal notices may be addressed, and file Form NR1 within 15 days of any address change.

V. Similar Trade Names & Industry Directory

Human Health & Social Work Activities→Kai Tak Factory Building (Stage 2) (5,370)→
Retrieve Filings